Cliff Asness's CC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 333,599 shares of The Chemours Company (CC) worth $3.93 M, representing 0.00% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in CC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2016, adding 1.12 M shares. Largest reduction occurred in Q3 2018, reducing 1.44 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's The Chemours Company (CC) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Chemours Company (CC) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +270,080 | Add 425.20% | 333,599 | $11.79 |
| Q3 2025 | +63,519 | New Buy | 63,519 | $15.63 |
| Q2 2025 | -11,920 | Sold Out | 0 | $0.00 |
| Q1 2025 | +11,920 | New Buy | 11,920 | $13.53 |
| Q3 2024 | -158,585 | Sold Out | 0 | $0.00 |
| Q2 2024 | +34,817 | Add 28.13% | 158,585 | $22.57 |
| Q1 2024 | -192,124 | Reduce 60.82% | 123,768 | $26.26 |
| Q4 2023 | +58,037 | Add 22.51% | 315,892 | $31.54 |
| Q3 2023 | -351,064 | Reduce 57.65% | 257,855 | $28.03 |
| Q2 2023 | -624,479 | Reduce 50.63% | 608,919 | $36.73 |
| Q1 2023 | -474,296 | Reduce 27.77% | 1.23 M | $29.52 |
| Q4 2022 | +40,556 | Add 2.43% | 1.71 M | $30.50 |
| Q3 2022 | +366,468 | Add 28.18% | 1.67 M | $24.65 |
| Q2 2022 | +167,555 | Add 14.79% | 1.3 M | $30.80 |
| Q1 2022 | +850,944 | Add 301.57% | 1.13 M | $31.48 |
| Q4 2021 | -16,395 | Reduce 5.49% | 282,171 | $33.56 |
| Q3 2021 | -159,746 | Reduce 34.86% | 298,566 | $29.06 |
| Q2 2021 | -422,669 | Reduce 47.98% | 458,312 | $34.80 |
| Q1 2021 | +184,316 | Add 26.46% | 880,981 | $27.91 |
| Q4 2020 | -37,244 | Reduce 5.07% | 696,665 | $24.79 |
| Q3 2020 | +626,919 | Add 585.96% | 733,909 | $20.80 |
| Q2 2020 | +87,241 | Add 441.75% | 106,990 | $15.09 |
| Q1 2020 | -47,569 | Reduce 70.66% | 19,749 | $8.86 |
| Q4 2019 | +11,720 | Add 21.08% | 67,318 | $17.77 |
| Q3 2019 | +2,499 | Add 4.71% | 55,598 | $14.95 |
| Q2 2019 | +12,981 | Add 32.36% | 53,099 | $23.99 |
| Q1 2019 | +40,118 | New Buy | 40,118 | $37.17 |
| Q4 2018 | -450,617 | Sold Out | 0 | $0.00 |
| Q3 2018 | -1.44 M | Reduce 76.17% | 450,617 | $39.44 |
| Q2 2018 | +289,099 | Add 18.04% | 1.89 M | $44.36 |
| Q1 2018 | -1.4 M | Reduce 46.65% | 1.6 M | $48.71 |
| Q4 2017 | +276,601 | Add 10.15% | 3 M | $50.06 |
| Q3 2017 | +1.01 M | Add 58.61% | 2.73 M | $50.61 |
| Q2 2017 | +898,307 | Add 109.47% | 1.72 M | $37.92 |
| Q1 2017 | -77,126 | Reduce 8.59% | 820,602 | $38.50 |
| Q4 2016 | -299,526 | Reduce 25.02% | 897,728 | $22.09 |
| Q3 2016 | -256,683 | Reduce 17.65% | 1.2 M | $16.00 |
| Q2 2016 | +1.12 M | Add 333.39% | 1.45 M | $8.24 |
| Q1 2016 | -237,132 | Reduce 41.41% | 335,479 | $7.00 |
| Q4 2015 | +572,611 | New Buy | 572,611 | $5.36 |
Cliff Asness's The Chemours Company Investment FAQs
Cliff Asness first purchased The Chemours Company (CC) in Q4 2015, acquiring 572,611 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held The Chemours Company (CC) for 40 quarters since Q4 2015.
Cliff Asness's largest addition to The Chemours Company (CC) was in Q2 2016, adding 1,453,937 shares worth $11.98 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 333,599 shares of The Chemours Company (CC), valued at approximately $3.93 M.
As of the Q4 2025 filing, The Chemours Company (CC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in The Chemours Company (CC) was 3,003,017 shares, as reported at the end of Q4 2017.